Uni-Bio Science (HK690) Appoints CEO, Non-Executive Director and Independent Non-executive Director Leveraging on Deep Industry Knowledge to Garner New Impetus
HONG KONG, April 9, 2019 /PRNewswire/ -- A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (the "Company", together with its subsidiaries, the "Group"; Stock code: 0690.HK), is pleased to announce the appointment of Mr.Zhao Zhi Gang as the CEO, Mr. Ma Qing Shan as indep...
Uni-Bio Science Group Limited Announces 2018 Annual Results
HONG KONG, March 30, 2019 /PRNewswire/ -- A fully integrated biopharmaceutical company –Uni-Bio Science Group Limited ("Uni-Bio Science", together with its subsidiaries referred to as the "Group", stock code: 0690.HK), is pleased to announce its annual results for the year ended31 December 2018 (...
Uni-Bio Science's Anti-diabetic Acarbose Oral Tablets BE Study Application Accepted by the National Medical Products Administration
HONG KONG, Jan. 4, 2019 /PRNewswire/ -- A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (the "Company", together with its subsidiaries, the "Group, Stock code: 0690.HK), is pleased to announce that the bioequivalence study ("BE Study") and its clinical materials on Ac...
Uni-Bio Science Group Limited Announces 2018 Interim Results
Enhanced Market Penetration of Core Marketed Products Pipeline Product Uni-PTH is Expected to Launch in 2019 HONG KONG, Aug. 25, 2018 /PRNewswire/ -- A fully integrated biopharmaceutical company --Uni-Bio Science Group Limited ("Uni-Bio Science", together with its subsidiaries referred to as the ...
Cedrus Reiterated Overweight Rating on Uni-Bio Science Group Limited with a June 2019 Price Target of HKD0.28
HONG KONG, Aug. 22, 2018 /PRNewswire/ -- Cedrus Investments issued a company update report on Uni-Bio Science Group Limited ("Uni-Bio Science" or "the Group") (stock code: 0690) on21 August 2018. In view of the Group's successful marketing strategies and partnerships as well as strong pipeline, C...
Mr. Winston Xue, General Manager of Uni-Bio Science Healthcare Limited Was Interviewed by Bioon.com
HONG KONG, June 5, 2018 /PRNewswire/ -- A leading integrated biopharmaceutical researcher, developer and manufacturer –Uni-Bio Science Group Limited ("Uni-Bio Science" or "the Group"; stock code: 0690) is pleased to announce that Bioon.com lately had an exclusive interview with Mr.Winston Xue, Ge...
Uni-Bio Science Group Limited Posts Its 2017 Annual Results
Formed Strategic Alliance with Industry Leader Restructured Marketing and Sales Platform to Enhance Competitive Advantage Laid Solid Foundation for Future Development HONG KONG, March 30, 2018 /PRNewswire/ -- A leading integrated biopharmaceutical researcher, developer and manufacturer Uni-Bio S...
